Marshall Wace’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-10,900
Closed -$1.88M 1165
2015
Q1
$1.88M Buy
10,900
+8,065
+284% +$1.18M 0.02% 475
2014
Q4
$326K Sell
2,835
-16,531
-85% -$2M ﹤0.01% 697
2014
Q3
$3.03M Buy
19,366
+17,304
+839% +$2.51M 0.04% 369
2014
Q2
$254K Sell
2,062
-1,238
-38% -$137K ﹤0.01% 794
2014
Q1
$342K Buy
+3,300
New +$338K 0.01% 682

Other funds holding SLXP

Marshall Wace's SLXP Position: Q2 2015 in Review

Marshall Wace sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 10,900 shares — an estimated $1.88M sold.

Marshall Wace first reported a position in SLXP in Q1 2014 and held it in 5 quarters. The position peaked at $3.03M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Marshall Wace reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Marshall Wace sold 10,900 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.88M.
  • Marshall Wace first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2014 and held it in 5 quarters.
  • Marshall Wace's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.03M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Marshall Wace's 13F filing for Q2 2015, filed 14 Aug 2015.